We reported the process of exposure, clinical characteristics, diagnosis and prognosis of an A IDS MESHD
patient with asymptomatic TRANS
COVID-19. In our report, we found the asymptomatic TRANS
is still shedding virus for at least 29 days. Therefore, we suggested that for individuals who had close contact TRANS
with diagnosed or suspected COVID-19 patients, in addition to isolation, medical observation, and further related testing if clinical symptoms appear in the observation period, it is best to collect nasopharyngeal and throat swab specimens and test for COVID-19 nucleic acid as early as possible. The purpose of this active detection is to screen out COVID-19 asymptomatic patients, and to avoid further transmission TRANS
through recessive source of i nfection. MESHD
Our findings will facilitate understanding of asymptomatic TRANS
COVID-19 and improve prevention strategies against COVID-19 transmission.